Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation
Srikanth Sadhu, Rajdeep Dalal, Jyotsna Dandotiya, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19
Chaolin Huang, Xujuan Hu, Delong Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
The Important Role of Interleukin-2 in COVID-19
Leila Ghanbari Naeini, Laleh Abbasi, Farzaneh Karimi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 15
Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity
Ramachandran Thiruvengadam, Zaigham Abbas Rizvi, Sreevatsan Raghavan, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 14
Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way
Zengguo Cao, Jiaqi Wang, Xiaolei Liu, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease
Rucha Chandwaskar, Rajdeep Dalal, Saurabh Gupta, et al.
Scandinavian Journal of Immunology (2024) Vol. 100, Iss. 6
Open Access | Times Cited: 5
Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction
Zhipeng Wu, Nan Geng, Zhao Liu, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
The emerging role of T helper 9 (Th9) cells in immunopathophysiology: A comprehensive review of their effects and responsiveness in various disease states
Manoj Khokhar, Purvi Purohit
International Reviews of Immunology (2024), pp. 1-20
Closed Access | Times Cited: 4
Gut commensals-derived succinate impels colonic inflammation in ulcerative colitis
Rajdeep Dalal, Srikanth Sadhu, Aashima Batra, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long COVID
Tamara Cruz, Núria Albacar, Estíbaliz Ruiz‐Ortiz, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters
Jyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
Natalie M. Kirk, Yuying Liang, Hinh Ly
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
VapC12 ribonuclease toxin modulates host immune response during Mycobacterium tuberculosis infection
Shaifali Tyagi, Srikanth Sadhu, Taruna Sharma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The potential use of medicinal plant extracts/products in the prevention of SARS-CoV2 infection and associated pathologies in the experimental models
Zaigham Abbas Rizvi, Amit Awasthi, Madhu Dikshit
Journal of Drug Research in Ayurvedic Sciences (2024) Vol. 9, Iss. 5, pp. 347-352
Open Access | Times Cited: 2
Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry
Srikanth Sadhu, Jyotsna Dandotiya, Rajdeep Dalal, et al.
Antiviral Research (2023) Vol. 220, pp. 105743-105743
Closed Access | Times Cited: 6
Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS‐CoV‐2
Sandhya Hora, Prabhjyoti Pahwa, Hamda Siddiqui, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 4
Berbamine prevents SARS-CoV-2 entry and transmission
Srikanth Sadhu, Sandeep Goswami, Ritika Khatri, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111347-111347
Closed Access | Times Cited: 1
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0302344-e0302344
Open Access
Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long covid
Tamara Cruz, Núria Albacar, Estíbaliz Ruiz‐Ortiz, et al.
Research Square (Research Square) (2024)
Open Access
VapC12 ribonuclease toxin modulates host immune response duringMycobacterium tuberculosisinfection
Shaifali Tyagi, Srikanth Sadhu, Taruna Sharma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top